Skip to main content
. 2017 Oct 10;12:33. doi: 10.1186/s13013-017-0138-7

Table 3.

Clinical treatment and Experimental injections

Pt. *1 1 2 3 4 5 6 7 8 9
Brace*2 Prov Prov Prov 0 Prov 0 Prov Prov Prov
IniBra*3 7.6 6.3 3.0 6 26.5 16.4 9.3
TermBra*4 52.4 21.7 *5 51.8 28 *6 67.9 42.7 31.7
TInj *7 10.7 2.87 13.45 11.94 1 10.4 51.2 5.9 13.37
IDose *8 100 100 100 100 100 100 100 100 420
TMusc *9 IP dex IP dex IP dex IP dex IP dex IP dex IP dex IP dex IPQE
Med. E *10 S, TBP – – – – NBP – – S, NBP
Surg. E – SU *13 SU *13 SU *13 cancelled SU *12 SU *14 – – –

*1 Patient ID *2 Type of Brace (Prov = Providence brace, 0 = no brace) *3 treated with Brace from time of diagnosis - initiation (months) *4 treated with brace from time of diagnosis - termination (months) *5 Brace abandoned due to physiological disorder of schizophrenia *6 omit brace treatment due to discomfort and psychological reasons *7 treated with injection from time of diagnosis (months) *8 Injection dose (Allergan units) *9 Injection in target muscles (IP = Iliopsoas, IPQE = Iliopsoas, quadratus lumborum and erector spinae, dex = right side, sin = left side) *10 clinical effects or adverse events after injection (S = soreness, NBP = no effect on back pain, TBP = temporary effect on back pain) * 11 surgical history at a later stage (SU = Spinal corrective surgery) *12 Su cancelled due to eating disorder and hormone treatment *13 correction at level Th4-L1 ad modem K2 M *14 correction at level Th3-L2 ad modem MESA Range + removal of cyst in medulla